Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

RAP1GAP SGSM1 PSD2 TRIO DOCK11 DOCK9 LRRK2 PSD3 RTKN RAB3GAP1 EIF2B1 FLCN PLCG1

9.19e-0550714613GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

RAP1GAP SGSM1 PSD2 TRIO DOCK11 DOCK9 LRRK2 PSD3 RTKN RAB3GAP1 EIF2B1 FLCN PLCG1

9.19e-0550714613GO:0030695
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

PSD2 TRIO DOCK11 DOCK9 PSD3 RAB3GAP1 EIF2B1 PLCG1

3.05e-042311468GO:0005085
GeneOntologyMolecularFunctionapolipoprotein A-I receptor binding

ABCA12 APOA1

3.16e-0441462GO:0034191
GeneOntologyBiologicalProcessresponse to amino acid starvation

SESN1 WDR59 EIF2B1 KICS2 FLCN EIF2AK4

4.06e-06611436GO:1990928
GeneOntologyBiologicalProcessprotein localization to endoplasmic reticulum

SEC16B LRRK2 VPS54 RYR2 RAB3GAP1 EDEM1

3.86e-05901436GO:0070972
GeneOntologyBiologicalProcesscellular response to amino acid starvation

SESN1 WDR59 KICS2 FLCN EIF2AK4

4.29e-05561435GO:0034198
GeneOntologyBiologicalProcessresponse to curcumin

ITGAM PLCG1

4.77e-0521432GO:1904643
HumanPhenoAntinuclear antibody positivity

DOCK11 TLR7 ITGAM C4A C4B EIF2AK4 PLCG1

3.04e-0572657HP:0003493
HumanPhenoAnti-U1 ribonucleoprotein antibody positivity

DOCK11 TLR7 ITGAM C4A C4B

4.47e-0532655HP:0033028
HumanPhenoAntineutrophil antibody positivity

DOCK11 TLR7 ITGAM C4A C4B EIF2AK4

4.90e-0553656HP:0003453
HumanPhenoExtractable nuclear antigen positivity

DOCK11 TLR7 ITGAM C4A C4B

6.05e-0534655HP:0033476
HumanPhenoDecreased circulating complement C4 concentration

TLR7 ITGAM C4A C4B PLCG1

6.99e-0535655HP:0045042
DomainARM-type_fold

DOCK11 DOCK9 LRRK2 USP24 CUL9 NBEA APOB PPP2R5B AOPEP DIAPH2 TAF2 SYMPK

1.28e-0533914412IPR016024
DomainPH

PSD2 TRIO DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

7.26e-052291449PF00169
DomainPH

PSD2 TRIO DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

3.11e-042781449SM00233
DomainPH_DOMAIN

PSD2 TRIO DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

3.20e-042791449PS50003
DomainPH_domain

PSD2 TRIO DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

3.28e-042801449IPR001849
DomainAnaphylatoxin_comp_syst

C4A C4B

5.81e-0451442IPR018081
DomainAnaphylatoxn_comp_syst_dom

C4A C4B

5.81e-0451442IPR001840
DomainDUF3398

DOCK11 DOCK9

8.68e-0461442PF11878
DomainDOCK_C/D_N

DOCK11 DOCK9

8.68e-0461442IPR021816
DomainANATO

C4A C4B

1.21e-0371442SM00104
DomainANAPHYLATOXIN_2

C4A C4B

1.21e-0371442PS01178
DomainANAPHYLATOXIN_1

C4A C4B

1.21e-0371442PS01177
DomainANATO

C4A C4B

1.21e-0371442PF01821
DomainAnaphylatoxin/fibulin

C4A C4B

1.21e-0371442IPR000020
DomainMacrogloblnA2_thiol-ester-bond

C4A C4B

1.60e-0381442IPR019565
DomainThiol-ester_cl

C4A C4B

1.60e-0381442PF10569
DomainMacrogloblnA2_CS

C4A C4B

1.60e-0381442IPR019742
DomainPH_dom-like

PSD2 TRIO DOCK11 DOCK9 PSD3 NBEA CNKSR2 RTKN IRS2 PLCG1

1.74e-0342614410IPR011993
DomainCalx_beta

ADGRV1 FREM1

2.05e-0391442IPR003644
DomainPH_dom-spectrin-type

PSD2 PSD3

2.05e-0391442IPR001605
Domainzf-C2H2_11

ZNF354B ZNF532

2.05e-0391442PF16622
DomainCalx-beta

ADGRV1 FREM1

2.05e-0391442PF03160
DomainGPS

ADGRG1 ADGRV1 ADGRL4

2.25e-03341443SM00303
Domain-

DDC ACCS MOCOS

2.45e-033514433.90.1150.10
DomainGPS

ADGRG1 ADGRV1 ADGRL4

2.45e-03351443PF01825
DomainLeu-rich_rpt_4

PODNL1 LRRK2

2.55e-03101442IPR025875
DomainLRR_5

TLR7 FSHR

2.55e-03101442PF13306
DomainLRR_5

TLR7 FSHR

2.55e-03101442IPR026906
DomainA2M

C4A C4B

2.55e-03101442PF00207
DomainA2M_N_2

C4A C4B

2.55e-03101442IPR011625
DomainA2M_comp

C4A C4B

2.55e-03101442IPR011626
DomainA2M_recep

C4A C4B

2.55e-03101442PF07677
DomainA2M_comp

C4A C4B

2.55e-03101442PF07678
DomainA2M_N

C4A C4B

2.55e-03101442PF01835
DomainA2M_N

C4A C4B

2.55e-03101442IPR002890
DomainA-macroglobulin_rcpt-bd

C4A C4B

2.55e-03101442IPR009048
DomainALPHA_2_MACROGLOBULIN

C4A C4B

2.55e-03101442PS00477
DomainRWD

WDR59 EIF2AK4

2.55e-03101442PS50908
DomainLRR_4

PODNL1 LRRK2

2.55e-03101442PF12799
DomainA2M_N_2

C4A C4B

2.55e-03101442PF07703
DomainMacroglobln_a2

C4A C4B

2.55e-03101442IPR001599
DomainPyrdxlP-dep_Trfase_major_sub2

DDC ACCS MOCOS

2.66e-03361443IPR015422
DomainGPS

ADGRG1 ADGRV1 ADGRL4

2.66e-03361443PS50221
DomainGPS

ADGRG1 ADGRV1 ADGRL4

2.88e-03371443IPR000203
DomainRWD

WDR59 EIF2AK4

3.10e-03111442SM00591
DomainDHR-1_domain

DOCK11 DOCK9

3.10e-03111442IPR027007
DomainDHR_2

DOCK11 DOCK9

3.10e-03111442PS51651
DomainDHR_1

DOCK11 DOCK9

3.10e-03111442PS51650
DomainDHR-2

DOCK11 DOCK9

3.10e-03111442PF06920
DomainDOCK

DOCK11 DOCK9

3.10e-03111442IPR026791
DomainDOCK_C

DOCK11 DOCK9

3.10e-03111442IPR010703
DomainDOCK-C2

DOCK11 DOCK9

3.10e-03111442PF14429
DomainDHR-2

DOCK11 DOCK9

3.10e-03111442IPR027357
Domain-

DDC ACCS MOCOS

3.35e-033914433.40.640.10
Domain-

PSD2 TRIO DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

3.36e-0339114492.30.29.30
DomainRWD-domain

WDR59 EIF2AK4

3.70e-03121442IPR006575
DomainPyrdxlP-dep_Trfase

DDC ACCS MOCOS

3.86e-03411443IPR015424
DomainPyrdxlP-dep_Trfase_major_sub1

DDC ACCS MOCOS

3.86e-03411443IPR015421
DomainPeptidase_M1_N

AOPEP TAF2

4.36e-03131442IPR014782
DomainPeptidase_M1

AOPEP TAF2

4.36e-03131442PF01433
Domain-

PSD2 PSD3

5.80e-031514421.10.1000.11
DomainSec7

PSD2 PSD3

5.80e-03151442PF01369
DomainSec7_alpha_orthog

PSD2 PSD3

5.80e-03151442IPR023394
DomainSEC7

PSD2 PSD3

6.60e-03161442PS50190
DomainSec7

PSD2 PSD3

6.60e-03161442SM00222
DomainSec7_dom

PSD2 PSD3

6.60e-03161442IPR000904
Domain7tm_2

ADGRG1 ADGRV1 ADGRL4

6.75e-03501443PF00002
DomainG_PROTEIN_RECEP_F2_2

ADGRG1 ADGRV1 ADGRL4

6.75e-03501443PS00650
DomainC345C

C4A C4B

7.44e-03171442SM00643
PathwayREACTOME_AMINO_ACIDS_REGULATE_MTORC1

ATP6V1C1 SESN1 WDR59 KICS2 FLCN

5.90e-05551075M29825
PathwayREACTOME_AMINO_ACIDS_REGULATE_MTORC1

ATP6V1C1 SESN1 WDR59 KICS2 FLCN

6.44e-05561075MM15667
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

TOR1AIP2 MYO6 TM9SF3 USP24 MUC16 PARD6G NBEA NEB ADCY2 RYR2 RAB3GAP1 SYNE2 KDM2B FLCN IRS2 TAF2

1.76e-086381491631182584
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

PITPNM2 SGSM1 TRIO MYO6 ASH1L TMEM63B NAPA ADGRG1 VPS54 ADGRV1 SESN1 TASOR2 ZNF532 WDR11 AOPEP NAV1 ASTN2 EIF2AK4 PLCG1 MED27 PBX3 VPS13B MOCOS

9.97e-0814891492328611215
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SEC16B RPS6KA5 RBBP8 USP24 GEMIN5 ITPRID2 THOC2 PTPRC CLN3 CTDP1 KDM2B IRS2 ESPL1 CLUH MOCOS SYMPK

2.44e-077741491615302935
Pubmed

B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency.

PTPRC C4A C4B

3.07e-074149319001138
Pubmed

A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis.

ITGAM C4A C4B

7.66e-07514939382884
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

PITPNM2 ZNF384 TRIO PIEZO1 DOCK9 GEMIN5 CUL9 WDR59 CLN3 CTDP1 DIAPH2 NAV1 FLCN IRS2 PLCG1 ESPL1 ANKRD16 SYMPK

1.32e-0611051491835748872
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

MYO6 DOCK11 DOCK9 SMC4 NBEA NEB DDX54 DIAPH2 C4A C4B IRS2 EIF2AK4

1.72e-064971491236774506
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

CFAP91 RAP1GAP TRIO MYO6 DIS3L ASH1L NAPA CUL9 NBEA VPS54 CMYA5 WDR59 TXNDC11 SMYD2 NAA25 ZNF532 ASTN2 PLCG1 PBX3

2.72e-0612851491935914814
Pubmed

C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens.

ITGAM C4A C4B

4.25e-068149324474777
Pubmed

Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.

PODNL1 ADGRV1 NEB FREM1 EXOC5 CTNNA3 ESPL1

4.43e-06152149734299191
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DOCK9 PSD3 CUL9 CNKSR2 ADCY2 EPG5 KANK1 PCDH19 NAV1 VPS13B

1.11e-054071491012693553
Pubmed

Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.

ITGAM C4A C4B

1.65e-0512149318524992
Pubmed

Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche.

ITGAM CLCA1 PTPRC

1.65e-0512149331201093
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

1.82e-052149222737222
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

1.82e-052149216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

1.82e-052149215998580
Pubmed

Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population.

APOA1 APOB

1.82e-052149219729689
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

1.82e-052149219062096
Pubmed

Apolipoprotein A1, B levels, and their ratio and the risk of a first stroke: a meta-analysis and case-control study.

APOA1 APOB

1.82e-052149226363640
Pubmed

Apolipoprotein A-I/apolipoprotein B ratio and aggression in violent and nonviolent young adult males.

APOA1 APOB

1.82e-052149216455106
Pubmed

Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.

APOA1 APOB

1.82e-052149229776362
Pubmed

Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.

APOA1 APOB

1.82e-052149215242863
Pubmed

The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population.

APOA1 APOB

1.82e-052149220213498
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

1.82e-052149219933335
Pubmed

ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.

APOA1 APOB

1.82e-052149229440006
Pubmed

Validation of human ApoB and ApoAI immunoturbidity assays for non-human primate dyslipidemia and atherosclerosis research.

APOA1 APOB

1.82e-052149221394531
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

1.82e-05214922459207
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

1.82e-052149217645767
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

1.82e-052149212207352
Pubmed

Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.

APOA1 APOB

1.82e-052149229154726
Pubmed

Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.

APOA1 APOB

1.82e-052149221129746
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

1.82e-052149227758680
Pubmed

Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers.

KHDRBS2 LRRK2

1.82e-052149225301747
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

1.82e-052149222387014
Pubmed

Apolipoprotein B/A-I ratio related to visceral but not to subcutaneous adipose tissue in elderly Swedes.

APOA1 APOB

1.82e-052149220382384
Pubmed

Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity.

KHDRBS2 LRRK2

1.82e-052149222342962
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

1.82e-052149223749435
Pubmed

Apolipoprotein B Level and the Apolipoprotein B/Apolipoprotein A-I Ratio as a Harbinger of Ischemic Stroke: A Prospective Observation in Taiwan.

APOA1 APOB

1.82e-052149232950994
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

1.82e-052149223918728
Pubmed

Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents.

APOA1 APOB

1.82e-052149221138461
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

1.82e-05214923037333
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

1.82e-052149211726230
Pubmed

Apo-B/AI ratio identifies cardiovascular risk in childhood: the Australian Aboriginal Birth Cohort study.

APOA1 APOB

1.82e-052149220368199
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

1.82e-05214924216347
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

1.82e-05214926950384
Pubmed

Crosstalk Between CD11b and Piezo1 Mediates Macrophage Responses to Mechanical Cues.

PIEZO1 ITGAM

1.82e-052149234630381
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

1.82e-05214928660986
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

1.82e-05214928428773
Pubmed

Clinical significance of serum apolipoproteins as a predictor of coronary heart disease risk in Korean men.

APOA1 APOB

1.82e-052149226118305
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

1.82e-052149224638111
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

1.82e-052149221345967
Pubmed

Apolipoprotein B/A-I Ratio Predicts Lesion Severity and Clinical Outcomes in Diabetic Patients With Acute Coronary Syndrome.

APOA1 APOB

1.82e-052149232418956
Pubmed

Association between Apolipoproteins AI and B and Ultrasound Indicators of Carotid Atherosclerosis.

APOA1 APOB

1.82e-052149229032752
Pubmed

Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.

APOA1 APOB

1.82e-052149220538481
Pubmed

Hyperhomocysteinemia is associated with decreased apolipoprotein AI levels in normal healthy people.

APOA1 APOB

1.82e-052149226758372
Pubmed

Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.

C4A C4B

1.82e-05214922572548
Pubmed

The complement component C4 of mammals.

C4A C4B

1.82e-05214922302180
Pubmed

LRRK2 expression is enriched in the striosomal compartment of mouse striatum.

KHDRBS2 LRRK2

1.82e-052149222850484
Pubmed

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.

C4A C4B

1.82e-052149222151770
Pubmed

C4d-positive chronic rejection: a frequent entity with a poor outcome.

C4A C4B

1.82e-052149218091514
Pubmed

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

C4A C4B

1.82e-052149229080553
Pubmed

Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.

APOA1 APOB

1.82e-052149225374385
Pubmed

Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.

C4A C4B

1.82e-05214926589636
Pubmed

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

C4A C4B

1.82e-052149225339671
Pubmed

A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.

C4A C4B

1.82e-052149217728371
Pubmed

Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study.

APOA1 APOB

1.82e-052149234851955
Pubmed

Structure and organization of the C4 genes.

C4A C4B

1.82e-05214926149580
Pubmed

Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.

C4A C4B

1.82e-05214926149581
Pubmed

The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.

APOA1 APOB

1.82e-052149219551315
Pubmed

ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.

APOA1 APOB

1.82e-052149216801176
Pubmed

The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

C4A C4B

1.82e-052149212115608
Pubmed

Biochemistry and biology of anaphylatoxins.

C4A C4B

1.82e-05214923542363
Pubmed

C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.

C4A C4B

1.82e-05214922387317
Pubmed

Associations of iron status with apolipoproteins and lipid ratios: a cross-sectional study from the China Health and Nutrition Survey.

APOA1 APOB

1.82e-052149232546165
Pubmed

APOA1 and APOB polymorphisms and apolipoprotein concentrations as biomarkers of risk in acute coronary syndrome: Relationship with lipid-lowering therapy effectiveness.

APOA1 APOB

1.82e-052149228992985
Pubmed

Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.

C4A C4B

1.82e-052149216908004
Pubmed

Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.

C4A C4B

1.82e-05214927365238
Pubmed

Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.

APOA1 APOB

1.82e-052149222674204
Pubmed

Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease.

APOA1 APOB

1.82e-052149237698922
Pubmed

Assessment of serum apolipoprotein B and apolipoprotein A-1 and their ratio in healthy full term small for gestational age newborns.

APOA1 APOB

1.82e-052149228304324
Pubmed

Association between Apolipoprotein B/Apolipoprotein A-1 and arterial stiffness in metabolic syndrome.

APOA1 APOB

1.82e-052149225025299
Pubmed

Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

C4A C4B

1.82e-05214927391573
Pubmed

Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

C4A C4B

1.82e-052149217971360
Pubmed

Deep subcortical infarct burden in relation to apolipoprotein B/AI ratio in patients with intracranial atherosclerotic stenosis.

APOA1 APOB

1.82e-052149223121297
Pubmed

Clinical features of patients with homozygous complement C4A or C4B deficiency.

C4A C4B

1.82e-052149229928053
Pubmed

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

C4A C4B

1.82e-052149217971229
Pubmed

Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.

C4A C4B

1.82e-05214926881182
Pubmed

The Apolipoprotein B/A1 Ratio is Associated With Metabolic Syndrome Components, Insulin Resistance, Androgen Hormones, and Liver Enzymes in Women With Polycystic Ovary Syndrome.

APOA1 APOB

1.82e-052149235069437
Pubmed

IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production.

IRS2 PLCG1

1.82e-05214929535722
Pubmed

Independent association of severity of obstructive sleep apnea with lipid metabolism of atherogenic index of plasma (AIP) and apoB/apoAI ratio.

APOA1 APOB

1.82e-052149231981042
Pubmed

ApoB/ApoA-I ratio is associated with increased risk of bioprosthetic valve degeneration.

APOA1 APOB

1.82e-052149223410546
Pubmed

Levels of lipids and apolipoproteins in three cultures.

APOA1 APOB

1.82e-052149219766218
Pubmed

Genetic association of the ApoB and ApoA1 gene polymorphisms with the risk for alcohol-induced osteonecrosis of femoral head.

APOA1 APOB

1.82e-052149226617857
Pubmed

Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study.

APOA1 APOB

1.82e-052149233794863
Pubmed

Partial C4 deficiency in juvenile idiopathic arthritis patients.

C4A C4B

1.82e-052149217921792
Pubmed

Predictive Models for the Risk of Dyslipidemia in Adolescents with Essential Arterial Hypertension.

APOA1 APOB

1.82e-052149230488199
Pubmed

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

C4A C4B

1.82e-052149221880985
Pubmed

Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.

C4A C4B

1.82e-05214926978711
Pubmed

Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.

APOA1 APOB

1.82e-052149225913481
Pubmed

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

C4A C4B

1.82e-052149235898513
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PSD2 DOCK11 DOCK9 PSD3 CNKSR2 RTKN IRS2 PLCG1

2.02e-052061018682
GeneFamilyComplement system|Sushi domain containing

ITGAM C4A C4B

1.06e-03361013492
GeneFamilyC3 and PZP like, alpha-2-macroglobulin domain containing

C4A C4B

1.08e-03910121234
GeneFamilyN(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases

NAA60 NAA25

1.97e-03121012660
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 FAT3 CNKSR2 APOB ADGRV1 NEB FREM1 RYR2 SPAG17

1.18e-0818414892cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 FAT3 CNKSR2 APOB ADGRV1 NEB FREM1 RYR2 SPAG17

1.18e-081841489ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 FAT3 CNKSR2 APOB ADGRV1 NEB FREM1 RYR2 SPAG17

1.18e-0818414892b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

LRRK2 MUC16 ADGRV1 RYR2 DIAPH2 NAV1 IRS2 SPAG17

2.11e-07186148823b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellTransverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass

CFAP91 MYO6 PSD3 NEB ZNF354B SMYD2 UTP15 AOPEP

3.27e-0719714888545baf923ddf84c5ce9414a36d810603be52401
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR17 ASIC1 DOCK9 LRRK2 USP24 CMYA5 KANK1 NAV1

3.53e-07199148819a97e27a4758e794ce7246d295e112b47931a48
ToppCell10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

CFAP47 CFAP91 RAP1GAP MUC16 HOGA1 SYNE2 SPAG17

9.34e-07156148710d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_large-bowel / Manually curated celltypes from each tissue

SGSM1 DIS3L CUL9 HELB ZNF532 AOPEP CLUH

9.75e-071571487d85304af4cd3b8aaedc5362a8223537e1b9dbec2
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 FAT3 ADGRV1 ADCY2 FREM1 RYR2 FSHR

1.11e-061601487c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCA12 FAT3 ADGRV1 ADCY2 FREM1 RYR2 FSHR

1.11e-06160148725c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellE12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SGSM1 PIEZO1 DOCK9 CUL9 HELB VPS13B FBXO15

1.79e-0617214873b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

RAP1GAP DOCK9 KHDRBS2 LRRK2 ADGRV1 KANK1 CTNNA3

3.59e-06191148734cc997e4e5c727495f321e6807a84aa124da486
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO DOCK11 FAT3 LRRK2 KANK1 SYNE2 ASTN2

3.59e-061911487d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYO6 KHDRBS2 LRRK2 TMEM63B ADGRV1 KANK1 CTNNA3

3.59e-061911487ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCellEpithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor

MYO6 KHDRBS2 LRRK2 TMEM63B ADGRV1 KANK1 CTNNA3

3.59e-061911487d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

RAP1GAP MYO6 DOCK9 KHDRBS2 LRRK2 ADGRV1 KANK1

3.72e-061921487fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO6 PIEZO1 PSD3 NBEA CMYA5 CREB3L1 FREM1

3.98e-0619414874579b4a44f7c731553a284843c296866027d7c0e
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO6 PIEZO1 PSD3 NBEA CMYA5 CREB3L1 FREM1

4.12e-0619514873d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9

GPR17 FAT3 CMYA5 RYR2 PDE8B CTNNA3

4.26e-0612714865e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

TRIO KHDRBS2 ADGRV1 KANK1 AOPEP DIAPH2 VPS13B

4.55e-0619814871996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

PITPNM2 TRIO DOCK9 ASH1L ITPRID2 SYNE2 DIAPH2

4.86e-062001487dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ABCA12 MUC16 ADGRV1 SLC30A3 CREB3L1 SLC9A1

8.78e-0614414863ba7f8bd6d1c551048403c94693d63e60f7cbbb7
ToppCellControl-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

PITPNM2 DOCK9 NAA25 DIAPH2 ACCS ZNF90

1.44e-0515714864803f601c1ba43260aa09172acc7964aac2c8ccf
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PODNL1 PSD2 SMC4 NEB SESN1 PTPRC

1.72e-051621486adf545cf9357556e2ce7affed01c2f6a24b0581d
ToppCellileum|World / shred on tissue and cell subclass

SEC16B APOA1 APOB ITPRID2 DDC CLCN2

2.25e-0517014869f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DOCK11 USP24 APOA1 CREB3L1 EPG5 PBX3

2.41e-051721486a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE6C TM9SF3 MUC16 CREB3L1 CLCA1 PDE8B

2.49e-0517314863aa1d28d4814798a772808ed29e1dbbdf92abd03
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PDE6C TM9SF3 MUC16 CREB3L1 CLCA1 PDE8B

2.49e-051731486e8afef5ae68983eb8d6515b43952636a47e9d3d4
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 ADCY2 CREB3L1 EPG5 PDE8B MOCOS

2.57e-05174148642f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)

USP24 APOA1 CREB3L1 EPG5 RAB3GAP1 PBX3

2.65e-051751486f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAP1GAP ABCA12 PIEZO1 TM9SF3 CREB3L1 IRS2

2.65e-051751486019ea30ac55748463d7917abf3d3f0e804189bfd
ToppCell5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAP1GAP ABCA12 PIEZO1 TM9SF3 CREB3L1 IRS2

2.92e-0517814869099b47e0756d6a1b7ba1c6aa7b47c5425f649e0
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KHDRBS2 LRRK2 ADGRV1 TXNDC11 KANK1 CTNNA3

3.01e-051791486815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NBEA ITPRID2 ADGRV1 DDC ADCY2 SPAG17

3.01e-0517914868ce5000088b727783a0619baa16a2cd036d21f54
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FAT3 CNKSR2 CREB3L1 FREM1 RYR2 ASTN2

3.11e-05180148608ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

MYO6 DOCK9 METTL5 PLCG1 CLUH SYMPK

3.11e-05180148681d60f0fa9e3b5bfcec85139a0a49e9130145f0e
ToppCellCOVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations)

PITPNM2 MYO6 DOCK9 KHDRBS2 ADGRL4 SYNE2

3.20e-051811486c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCellCOVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type

SEC16B DOCK11 KHDRBS2 LRRK2 SYNE2 ASTN2

3.51e-05184148651ed1ebfdef45149541917c66cbacad87072e51f
ToppCell(7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

FAT3 PSD3 CREB3L1 PDE8B NAV1 KDM2B

3.51e-051841486b89871a3e36fde6daa68daf116f8c8d587554c0f
ToppCelldroplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 DOCK9 PARD6G RTKN SMYD2 CLCA1

3.62e-0518514863a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCelldroplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 DOCK9 PARD6G RTKN SMYD2 CLCA1

3.62e-051851486224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CFAP91 WDR11 SOCS5 PLCG1 VPS13B ZFP62

3.73e-05186148677bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CFAP91 WDR11 SOCS5 PLCG1 VPS13B ZFP62

3.73e-05186148613bc41c60fd628af31899a5e8b480e06cc4781be
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

PSD3 CMYA5 NEB RYR2 PDE8B CTNNA3

3.96e-0518814866d249fe92d51a19da19ec14bb2262d394255d577
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

ASH1L USP24 TASOR2 EPG5 PTPRC SYNE2

3.96e-051881486ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM229A ACOT7 ADGRV1 RTKN CLN3 C4B

3.96e-05188148687fd5e2dd01583baf7e018bff8750d20a557a20f
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK11 FAT3 LRRK2 KANK1 SYNE2 ASTN2

4.08e-051891486904b8337e2cabac2f0bf5dad5598fc429581ed81
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PITPNM2 TRIO RBBP8 ADGRV1 AOPEP SYNE2

4.08e-0518914868c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PITPNM2 TRIO RBBP8 ADGRV1 AOPEP SYNE2

4.08e-0518914865d902a4660a27548764bf04c6de152b565da835c
ToppCellRV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

PSD3 CMYA5 SMYD2 RYR2 AOPEP CTNNA3

4.08e-0518914860a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCellLPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RPS6KA5 ADGRG1 APOA1 ITPRID2 ADGRL4 NAV1

4.20e-051901486aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCellLPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RPS6KA5 DOCK9 APOA1 ITPRID2 ADGRL4 NAV1

4.32e-0519114864b3d5157344dbfbf4fab518611cd9fa37fac7bd9
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYO6 KHDRBS2 LRRK2 TMEM63B SMC4 ADGRV1

4.45e-05192148629f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

RAP1GAP DOCK9 LRRK2 ADGRV1 CREB3L1 KANK1

4.45e-05192148606013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class

CFAP91 PSD3 MUC16 NBEA CEP126 SPAG17

4.45e-0519214869cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCellrenal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

TRIO ASH1L KANK1 AOPEP SYNE2 VPS13B

4.45e-051921486e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCellPCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

KLHL6 LRRK2 TLR7 ITGAM S100A12 PTPRC

4.58e-051931486c9e3fefa8d68d0e2b954f85ce37813185ff98d84
ToppCellFetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MYO6 KHDRBS2 LRRK2 ADGRV1 KANK1 CTNNA3

4.58e-051931486a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

MYO6 CMYA5 KANK1 AOPEP SYNE2 ASTN2

4.72e-0519414867002937e8903e037332a215d00fbc7c7843b33f2
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

PSD3 CMYA5 RYR2 PDE8B CTNNA3 ASTN2

4.72e-05194148689812fb164065041357bb37a3c2d87028ec3de4e
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

PSD3 CMYA5 RYR2 PDE8B CTNNA3 ASTN2

4.72e-051941486c3535f7cc0076653c72db582047cff053c322397
ToppCell3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CFAP47 CFAP91 MUC16 NBEA CEP126 SPAG17

4.72e-0519414864a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

ADGRV1 KANK1 FARS2 AOPEP DIAPH2 VPS13B

4.99e-051961486ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellCOVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type

PITPNM2 MYO6 DOCK9 KHDRBS2 ADGRL4 SYNE2

4.99e-05196148649cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR17 ASIC1 CMYA5 RTKN PDE8B NAV1

4.99e-051961486f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR17 ASIC1 CMYA5 RTKN PDE8B NAV1

4.99e-051961486671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCellCOVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type

PITPNM2 MYO6 DOCK9 KHDRBS2 ADGRL4 SYNE2

4.99e-0519614864ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYO6 RBBP8 LRRK2 KANK1 SYNE2 ASTN2

5.14e-0519714867e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCellTransverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype

CFAP91 LRRK2 PSD3 NEB ZNF354B AOPEP

5.14e-05197148615b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCellTransverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass

CFAP91 LRRK2 PSD3 NEB ZNF354B AOPEP

5.14e-051971486a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR17 ASIC1 DOCK9 USP24 KANK1 NAV1

5.43e-051991486333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

GPR17 ASIC1 DOCK9 USP24 KANK1 NAV1

5.43e-051991486e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCellBronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

RAP1GAP MUC16 NBEA CMYA5 CREB3L1 PDE8B

5.58e-052001486292c63693eb7f435335a8cfba07aa35b72139393
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DOCK9 ADGRG1 APOA1 ITPRID2 ADGRL4 SYNE2

5.58e-05200148677ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCellNeuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic

FAT3 KHDRBS2 PSD3 CNKSR2 SLC30A3 RYR2

5.58e-0520014864409065bc7aa995354c71e0f9d6f3726cf393d6b
ToppCellLPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type

DOCK9 ADGRG1 APOA1 ITPRID2 ADGRL4 SYNE2

5.58e-052001486b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells)

ABCA12 MUC16 ITGAM SLC30A3 SLC9A1

1.09e-041411485e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

RPS6KA5 HELB PTPRC SYNE2 ZNF90

1.16e-041431485eb11ff288cb91210383b288aa57715ebd59a52c3
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

ASIC1 PARD6G DDC FREM1 PBX3

1.41e-04149148598ae408d2d0347865875ff8bbd89d359decea526
ToppCellLPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP91 ADCY2 CEP126 SPAG17 FBXO15

1.64e-0415414859ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCellLPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP91 ADCY2 CEP126 SPAG17 FBXO15

1.64e-04154148558072ce422d09f2de602580325eaac6c4ec6c136
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP91 ADCY2 CEP126 SPAG17 FBXO15

1.69e-0415514855f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CFAP91 ADCY2 CEP126 SPAG17 FBXO15

1.69e-0415514850944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SGSM1 RPS6KA5 FAM81A KICS2 PLCG1

1.80e-041571485a426c54fd1545093d41426e9620862f71bd06f6b
ToppCellPND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 DOCK9 PARD6G RTKN CLCA1

2.02e-041611485133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 DOCK9 PARD6G RTKN CLCA1

2.02e-0416114859466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

PIEZO1 APOA1 CCDC77 LINC00869 ZNF532

2.02e-0416114852fe77af3b41e6eacb707a64feea18f9991618173
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 DOCK9 PARD6G RTKN CLCA1

2.02e-041611485cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 DOCK9 PARD6G RTKN CLCA1

2.08e-04162148596c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCellBasal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

ASIC1 KHDRBS2 PARD6G RYR2 CEP126

2.20e-041641485b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 KHDRBS2 PARD6G RTKN CLCA1

2.20e-0416414854cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCelldroplet-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PODNL1 CFAP91 PSD2 ACOT7 DDC

2.20e-0416414857a51365bad2910c130bd952805f7a1bef51be481
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 KHDRBS2 PARD6G RTKN CLCA1

2.20e-0416414857a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 KHDRBS2 PARD6G RTKN CLCA1

2.20e-0416414855e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCellPND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SGSM1 KHDRBS2 PARD6G RTKN CLCA1

2.20e-041641485f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCelldroplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APOA1 CNKSR2 DDC ESPL1 PADI3

2.33e-0416614850a7992bc673fca546636563ec3fc17a4298ab6b1
ToppCell356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells)

DOCK11 USP24 APOA1 EPG5 SYNE2

2.33e-041661485c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCellPND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KHDRBS2 MUC16 KANK1 SYNE2 C4B

2.39e-041671485c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ASIC1 MUC16 CREB3L1 SYNE2 C4B

2.39e-0416714857abc785e688a384672d7fb5a62d32538fe7e5a51
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ASIC1 ETFBKMT FREM1 PCDH19 ASTN2

2.39e-04167148555c3c68af269fcf40f2b080ae4489523609ad388
DrugAdvicor

APOA1 APOB SYNE2

2.61e-0651473CID000151176
Diseaseproprotein convertase subtilisin/kexin type 9 measurement

USP24 CNKSR2 APOB ADGRL4

3.52e-06221424EFO_0009312
Diseaseobstructive nephropathy (implicated_via_orthology)

EXOC5 MOCOS

2.30e-0521422DOID:0070314 (implicated_via_orthology)
Diseasesystemic lupus erythematosus (implicated_via_orthology)

TLR7 PTPRC C4A C4B

5.48e-05431424DOID:9074 (implicated_via_orthology)
DiseaseAtaxia with vitamin E deficiency

APOA1 APOB

6.88e-0531422C1848533
Diseasevery low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio

PITPNM2 SEC16B USP24 PSD3 APOB ITGAM SYNE2

1.04e-042221427EFO_0008317, EFO_0020943
DiseaseBehcet Syndrome

APOA1 APOB C4A

2.05e-04241423C0004943
Diseasenephrotic syndrome (biomarker_via_orthology)

APOA1 APOB DDC

2.05e-04241423DOID:1184 (biomarker_via_orthology)
DiseaseARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2

RYR2 CTNNA3

2.28e-0451422C1832931
Diseasetotal cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer

ABCA12 APOB SLC30A3 PLCG1

3.49e-04691424EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992
Diseasecystic fibrosis (implicated_via_orthology)

CLCN2 EDEM1

8.10e-0491422DOID:1485 (implicated_via_orthology)
Diseasephosphatidylcholine 36:1 measurement

TMEM229A ZNF532

1.01e-03101422EFO_0010379
Diseasefamilial hypercholesterolemia (is_implicated_in)

APOA1 APOB

1.01e-03101422DOID:13810 (is_implicated_in)
DiseaseDiabetic Cardiomyopathies

APOA1 RYR2

1.23e-03111422C0853897
Diseasepulmonary function measurement, forced expiratory volume, smoking behaviour measurement

ASTN2 PADI3

1.47e-03121422EFO_0003892, EFO_0004314, EFO_0005671
DiseaseAmino Acid Metabolism, Inherited Disorders

SECISBP2 EIF2AK4

1.73e-03131422C0750905
DiseaseAmino Acid Metabolism, Inborn Errors

SECISBP2 EIF2AK4

1.73e-03131422C0002514
Diseasevery low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

PITPNM2 SEC16B USP24 PSD3 APOB SYNE2

1.80e-032641426EFO_0008317, EFO_0020944
Diseasetotal cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement

APOB SLC30A3 PLCG1

1.92e-03511423EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928
DiseaseCondition, Preneoplastic

PSD2 TRIO AOPEP DDX54

2.00e-031101424C0282313
DiseasePrecancerous Conditions

PSD2 TRIO AOPEP DDX54

2.00e-031101424C0032927
Diseaseovarian cancer (is_implicated_in)

MYO6 MUC16 APOB

2.51e-03561423DOID:2394 (is_implicated_in)
Diseasetriglycerides in LDL measurement

PSD3 APOB SYNE2

2.51e-03561423EFO_0022320
Diseasemethylcobalamin deficiency type cblE, brain serotonin transporter measurement

TRIO PSD3

2.64e-03161422EFO_0004569, MONDO_0009354
Diseasefasting blood glucose measurement

PDE6C FAT3 CREB3L1 KANK1 CLCA1 KDM2B

2.73e-032871426EFO_0004465
DiseaseIGA glomerulonephritis

ITGAM ACCS PADI3

2.77e-03581423EFO_0004194
Diseaseadverse effect, response to xenobiotic stimulus

CTDP1 CTNNA3 ASTN2

2.91e-03591423EFO_0009658, GO_0009410
DiseaseAntibody Deficiency Syndrome

EPG5 C4A

2.98e-03171422C0003257
Diseaseresponse to opioid

MUC16 CTDP1 PBX3

3.20e-03611423EFO_0008541
DiseaseChild Behaviour Checklist assessment

PDE6C KANK1

3.35e-03181422EFO_0005661
Diseasesystemic lupus erythematosus (is_implicated_in)

APOA1 C4A C4B

3.35e-03621423DOID:9074 (is_implicated_in)
DiseaseSarcomatoid Renal Cell Carcinoma

LRRK2 SYNE2 FLCN OR4C13

3.46e-031281424C1266043
DiseaseChromophobe Renal Cell Carcinoma

LRRK2 SYNE2 FLCN OR4C13

3.46e-031281424C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

LRRK2 SYNE2 FLCN OR4C13

3.46e-031281424C1266044
DiseasePapillary Renal Cell Carcinoma

LRRK2 SYNE2 FLCN OR4C13

3.46e-031281424C1306837
DiseaseRenal Cell Carcinoma

LRRK2 SYNE2 FLCN OR4C13

3.46e-031281424C0007134
Diseasecerebral infarction (is_marker_for)

APOB ITGAM

3.73e-03191422DOID:3526 (is_marker_for)
Diseasehearing loss

MYO6 ITGAM UTP15

4.17e-03671423EFO_0004238
Diseaserenal cell carcinoma (is_implicated_in)

FLCN C4A C4B

4.53e-03691423DOID:4450 (is_implicated_in)
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

SEC16B USP24 PSD3 APOB ITGAM

4.75e-032251425EFO_0008317, EFO_0020947

Protein segments in the cluster

PeptideGeneStartEntry
HSVKSLSVFHAQLAY

PPP2R5B

286

Q15173
VAHVSAEITYTSKHS

ACOT7

121

O00154
LHVVHASVVTAYLFT

ADGRL4

636

Q9HBW9
IEKTREHYHATALGA

CTDP1

651

Q9Y5B0
EHYHATALGAKILTR

CTDP1

656

Q9Y5B0
KSEHLHQTLALHSYT

EPG5

371

Q9HCE0
VKHTSDNIHSASLYT

ASH1L

2381

Q9NR48
HLDSTHETTKYLSEA

CREB3L1

471

Q96BA8
VDVRATSTHLTALHY

ANKRD16

266

Q6P6B7
TALHYAAKEGHTSTI

ANKRD16

276

Q6P6B7
YIEQTHTKLEHSVCA

RBBP8

186

Q99708
HAAAITAYALTLTKA

C4B

1191

P0C0L5
SGLDYLHSNSVVHKV

EIF2AK4

411

Q9P2K8
NHARLKAAHTYVSEE

ACCS

381

Q96QU6
HDVLFSYLTTKEHLL

ABCA12

1426

Q86UK0
HLTKALSTFIHAEDF

GPR15

336

P49685
KASHHALVSLAVAFT

GPR17

216

Q13304
ESHVTLSLHYKTLGS

ADGRV1

1391

Q8WXG9
HHTQELLYESTKDFL

CCDC77

276

Q9BR77
ANTSHILVKHYVLDL

AOPEP

16

Q8N6M6
ARLAEYHAKATEHLS

APOA1

211

P02647
KHECTLSSQEYVHEL

DIAPH2

156

O60879
TYLKHSHQDSGLITD

DDC

331

P20711
QKSASTEATHEIHYI

ASTN2

241

O75129
VKVHHSTISSYLEDI

CFAP91

636

Q7Z4T9
KHILAAHQIIHSYTE

CFAP91

721

Q7Z4T9
KFSVTHHYLVQESTD

RAB3GAP1

71

Q15042
LSAEHKTTYEGLQHL

FAM81A

146

Q8TBF8
SSYELIVVAHDHGKT

PCDH19

636

Q8TAB3
HERLTTYKDTAHTEA

MUC16

7751

Q8WXI7
LYAAKTAVTAAHAVA

PBX3

306

P40426
DTLHHILKSDDLYVT

KLHL6

216

Q8WZ60
SSAALIHHYTKVADL

HOGA1

146

Q86XE5
ISHDKETSIKYVSHQ

FLCN

96

Q8NFG4
TTAQDHCKAIYLHVL

NAA60

126

Q9H7X0
AAAVTSLHKDHYENL

JMJD7

171

P0C870
LDHKVTGDLFYTHVT

SLC43A1

241

O75387
TVVFVATKHHAEYLT

DDX54

341

Q8TDD1
ATKHHAEYLTELLTT

DDX54

346

Q8TDD1
HTFIKDGATILTHAY

EIF2B1

116

Q14232
GSSILERHHLEYSKT

PDE6C

626

P51160
VLYNDTAVLESHHTA

PDE8B

676

O95263
SHHTALAFQLTVKDT

PDE8B

686

O95263
FTVYVTDGKHHSLEI

FREM1

1121

Q5H8C1
LHYSVSHSNFEIVKL

KANK1

1166

Q14678
SFSKLLVHHSFDLVI

LRRK2

661

Q5S007
ILAHFHTTAEDYTVI

MOCOS

101

Q96EN8
TLHYAFQTETKLHLI

RPS6KA5

116

O75582
SLVAKLEHYDLQATH

GGN

636

Q86UU5
KVTDHATTALLHYQL

MED27

241

Q6P2C8
YSLKTHSLEARHEAL

OR4C13

221

Q8NGP0
AALFDDHKLVLHTSS

PADI3

191

Q9ULW8
HLRVHAAYGSTKDVA

PITPNM2

1201

Q9BZ72
QYTTHHILKSLASIE

ITPRID2

656

P28290
YKLVVHTHHISNSDV

PARD6G

46

Q9BYG4
AALAHLAAAEKVYHS

KICS2

56

Q96MD2
TAVYSLHKSSTREHV

METTL5

151

Q9NRN9
TFSKLHSLEYLDLSH

PODNL1

261

Q6PEZ8
SSAFIKAQELHALTH

ERVK-18

586

Q9QC07
ASIDFLSHHLKEATI

IRS2

1321

Q9Y4H2
YVASILHATIHTVAT

OR5T1

161

Q8NG75
IKEYAAIFHEHTSRL

CTNNA3

411

Q9UI47
EHISYVATKVCHLGD

EXOC5

101

O00471
HISSVTLEHLNGAYK

ADCY2

426

Q08462
IKHIYAISSAALSAS

APOB

1836

P04114
YAQLHLEEAASSLKH

ESPL1

831

Q14674
YNVISLEFSHTKLEH

KDM2B

171

Q8NHM5
HLESTIYTQDLHVHK

DOCK11

816

Q5JSL3
HLYDTLHRAYSKVTE

DOCK9

1756

Q9BZ29
HTSYVGEQHLALEKT

C4orf45

36

Q96LM5
HSLIAKYNLSHLTIS

FBXO15

266

Q8NCQ5
HEEIYLTLNKEHSTS

CEP126

261

Q9P2H0
HDGKLLSSDVTHYVI

DIS3L

46

Q8TF46
EVKKEDVYSAHHSIS

CMYA5

421

Q8N3K9
LSAHNYKIEHTETDT

TMEM63B

736

Q5T3F8
HKLSYTVHSSIDSIS

FAT3

1491

Q8TDW7
SSVEVDAVHKHYLSL

ADGRG1

391

Q9Y653
YATLHHVIDKSTEDR

EDEM1

531

Q92611
EAKYAHLSDELHVLI

KHDRBS2

121

Q5VWX1
AVLHTIHVLSAYASI

CUL9

141

Q8IWT3
HHLHKVVEYSLLEST

ETFBKMT

231

Q8IXQ9
LLIASVDIHTKSQYH

FSHR

416

P23945
FTITDEKVHLYHSIE

SLC15A5

6

A6NIM6
SLDSSSHRIIAVHYV

RYR2

4546

Q92736
LQSLSVKSFHHVYLA

CFAP47

501

Q6ZTR5
HHSCLYSAVKTLLQE

HELB

716

Q8NG08
HAAAITAYALTLTKA

C4A

1191

P0C0L4
LSTESIHGYSISHVK

NAV1

1481

Q8NEY1
LHTFLEKHSTSDFLI

NAV1

1726

Q8NEY1
YHLLAHTTLTLAAVQ

RTKN

256

Q9BST9
HTKAVHTVDFTADKY

UTP15

121

Q8TED0
HELYKHLDSSAAAII

ATP6V1C1

336

P21283
ETLKCLSHHVADAYT

TOR1AIP2

306

Q8NFQ8
LSHHVADAYTSSQKV

TOR1AIP2

311

Q8NFQ8
HAVVLLTHYHSLASF

SESN1

201

Q9Y6P5
VFHSSTVTGLLEHYK

SOCS5

446

O75159
TLHLASTYLSHQEKL

SYNE2

2126

Q8WXH0
LHSLTHFALEKVYLQ

TMEM229A

96

B2RXF0
SLVAIALKAAHYHTH

S100A12

76

P80511
HTKHIAFLFDSTLTA

LINC00869

46

P0C866
LYEDLSCLLHKHVSA

SLC25A51

101

Q9H1U9
LLKHTTSYLHEVFEF

TAF2

276

Q6P1X5
THKFRLHVTALDYLA

NIP7

76

Q9Y221
TLSIAHSKVTYEAHK

NBEA

941

Q8NFP9
AALLETLYEELHIHS

RAP1GAP

391

P47736
EIKSARGSHHLSIYA

SECISBP2

171

Q96T21
VHHAVNALSKSVYEK

MYH3

421

P11055
LGEVVHTFSHIKLTY

MUTYH

436

Q9UIF7
AKHHISIAEIYETEL

NAPA

121

P54920
YIKTSHNHLLIVSTA

ITGAM

1056

P11215
SHVTEVAAHLTDLFK

SPAG17

1836

Q6Q759
YHHVTKLDEVAASQL

ASIC1

71

P78348
SYVVMLSAAHDILSH

CLN3

51

Q13286
DHGTAHKYIIRISTS

CLCA1

781

A8K7I4
THTIFSLLGVDHAYV

CLCN2

806

P51788
VDVITSSLAHTHSYI

CNKSR2

1016

Q8WXI2
ALSHHLVARVYESKA

CLUH

1146

O75153
HCNVVYSDVAALKSH

ZNF532

846

Q9HCE3
AYTDAASLEVHLSTH

ZNF384

411

Q8TF68
HLSTHTVKHAKVYTC

ZNF384

421

Q8TF68
YKTAEHHKDICLTVT

ZNF384

551

Q8TF68
FSVSSALIYHKRIHT

ZNF735

306

P0CB33
KASVHCLETGEYTHI

THOC2

1106

Q8NI27
LSAAYITSHLKTHGQ

VEZF1

296

Q14119
HHALATRASDYSKKS

PSD2

576

Q9BQI7
AEYSSLRKHLVVHSG

ZNF410

321

Q86VK4
AASHLLSIHKVYEAV

GEMIN5

981

Q8TEQ6
SDVLHTIKEHAFVAS

PLCG1

391

P19174
KTLSSLALVFALHHY

SMC4

1196

Q9NTJ3
YVEANISHKSHTTIK

SLC9A1

366

P19634
KHVSSAHYVLFIALA

SGSM1

1081

Q2NKQ1
HKLEVLDISSNSHYF

TLR7

566

Q9NYK1
HYTVKTDHLVLLGSS

SEC16B

576

Q96JE7
NHKLIHELAAVYTEA

SYMPK

801

Q92797
LTLTYHVASAHLAID

SLC30A3

326

Q99726
STAVEYLAAHLSKIH

WDR59

181

Q6PJI9
HLAKLVSLVHSGSVY

TXNDC11

306

Q6PKC3
KSISHYHETLGEALQ

TM9SF3

71

Q9HD45
SSSILYVHKISHTEE

ZNF90

296

Q03938
HGHLLTLNVTYESTK

USP24

956

Q9UPU5
AEFILDSTHHKETYT

VPS13B

511

Q7Z7G8
YSSVLDQHKRIHTGE

ZFP62

236

Q8NB50
YLSSLSTHKIIHTGE

ZNF66

296

Q6ZN08
SVEHSYALLLTEHSK

TASOR2

651

Q5VWN6
FHDILHTKYRAATDV

PIEZO1

1946

Q92508
ESHVHSLLSILRYGA

PPIP5K2

826

O43314
SSLTNHYKIHIEEDS

ZNF354B

591

Q96LW1
VAAHYLHSLSQEKSA

WDR11

931

Q9BZH6
KDLIQSDIAALHHFY

SMYD2

146

Q9NRG4
HAYVYLVSKASHISR

FARS2

11

O95363
FILHHSTSYNSKALI

PTPRC

566

P08575
VSVHHALASKATDYE

PSD3

846

Q9NYI0
YSSALIRHQKVHTGE

ZNF17

341

P17021
ASANYSKAVHHVLDV

TRIO

526

O75962
ITKDYHDHIAEISAK

VPS54

846

Q9P1Q0
TLHITAAVHDLSATY

TRAV39

91

A0A0B4J263
DALAKTVYSHLFDHV

MYO6

421

Q9UM54
VDLYSSLDAKHIQHD

NAA25

526

Q14CX7
IASDVDYKHILHSYS

NEB

911

P20929